Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
Clinical trial NCT07708961 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07708961
- Sponsor
- Mayo Clinic
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-16
- Primary completion
- 2036-07-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.